| PERIOD ENDING | 31-Mar-09 | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | | Total Revenue | 37,425 | 48,214 | 91,809 | 21,173 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 37,425 | 48,214 | 91,809 | 21,173 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,457 | 5,711 | 6,207 | 6,901 | | Non Recurring | 10,355 |
-
|
-
|
-
| | Others | 58,770 | 13 | 22 | 105 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (40,157) | 42,490 | 85,580 | 14,167 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (10,363) | (625) | (49,550) |
-
| | Earnings Before Interest And Taxes | (52,286) | 41,865 | 36,023 | 14,174 | | Interest Expense | 21,268 | 28,175 | 70,743 |
-
| | Income Before Tax | (73,554) | 13,690 | (34,720) | 14,174 | | Income Tax Expense | (408) | 26 | 98 | (599) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (73,146) | 13,664 | (34,818) | 14,773 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (73,146) | 13,664 | (34,818) | 14,773 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($73,146) | $13,664 | ($34,818) | $14,773 |
|
0.51% Nasdaq 
0.01 (0.91%) 
Income Statement
